| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/16/2009 | WO2006138449A3 Method for identifying a mhc class ii-dependent tumor-associated t helper cell antigen |
| 04/16/2009 | WO2006137938A3 Antibody fragments for protection from pathogen infection and methods of use thereof |
| 04/16/2009 | WO2006130769A3 Methods for treatment of growth disorders |
| 04/16/2009 | WO2006125165A3 Methods and compositions facilitating entry of compounds into cells |
| 04/16/2009 | WO2006113311A3 Compositions and uses of a galectin for treatment of dry eye syndrome |
| 04/16/2009 | WO2006110924A3 Dietary supplement formulations for improved delivery of coenzyme q10 and methods of administration |
| 04/16/2009 | WO2006105488A3 Antibodies and related molecules that bind to 161p2f10b proteins |
| 04/16/2009 | WO2006104778A3 Compositions and methods for detecting protease activity |
| 04/16/2009 | WO2006102612A3 Extracting reagent for hydrophobic analyte in whole blood |
| 04/16/2009 | WO2006102521A3 Methods of determining compounds useful in the treatment of bipolar disorder and methods of treating such disorders |
| 04/16/2009 | WO2006102498A3 Methods of diagnosing fetal trisomy 13 or a risk of fetal trisomy 13 during pregnancy |
| 04/16/2009 | WO2006099620A3 Rage/diaphanous interaction and related compositions and methods |
| 04/16/2009 | WO2006094068A3 Hdac inhibitors that promote brm expression and brm related diagnostics |
| 04/16/2009 | WO2006093814A3 Fgf growth factor analogs |
| 04/16/2009 | WO2006091930A3 Methods and compounds for promoting vessel regression |
| 04/16/2009 | WO2006091459A3 Compositions and methods for treating vascular permeability |
| 04/16/2009 | WO2006089156A3 Drug-polymer conjugates coupled to a peptidic carrier |
| 04/16/2009 | WO2006089095A3 Treating neurological disorders |
| 04/16/2009 | WO2006088624A3 Stabilized compositions containing natriuretic peptides |
| 04/16/2009 | WO2006083937A3 Agents and methods related to reducing resistance to apoptosis-inducing death receptor agonists |
| 04/16/2009 | WO2006083562A3 Method and multicomponent conjugates for treating cancer |
| 04/16/2009 | WO2006083276A3 Interferon-alpha polypeptides and conjugates |
| 04/16/2009 | WO2006062559A3 Device for enhancing tissue glucose processing |
| 04/16/2009 | WO2006058043A3 Contraceptive vaccines for dogs and cats based on egg membrane antigens |
| 04/16/2009 | WO2006055008A3 Implantable sensors and implantable pumps and anti-scarring agents |
| 04/16/2009 | WO2006045062A3 Pot1 alternative splicing variants |
| 04/16/2009 | WO2006032016A3 P49/strap is a novel protein involved in gene regulation and cell proliferation |
| 04/16/2009 | WO2006032011A3 Combination therapy for controlled carbohydrate digestion |
| 04/16/2009 | WO2006023332A3 Method for the inhibition of angiogenesis or cancer using protective antigen related molecules |
| 04/16/2009 | WO2006017563A3 Compositions and methods for reversing age-related changes in extracellular matrix proteins |
| 04/16/2009 | WO2006017184A3 HYBRID PROTEINS WITH ErbB4 EXTRACELLULAR DOMAIN AND NEUREGULIN HEPARIN-BINDING DOMAIN FOR TARGETING |
| 04/16/2009 | WO2006016282A3 Media indexer |
| 04/16/2009 | WO2005115477A3 Non-natural ribonuclease conjugates as cytotoxic agents |
| 04/16/2009 | WO2005112986A3 Purifying chondroitinase and stable formulations thereof |
| 04/16/2009 | WO2005084116A3 Calcium channel variants |
| 04/16/2009 | WO2005081699A3 Biomimetic organic/inorganic composites, processes for their production, and methods of use |
| 04/16/2009 | WO2005069994A3 Folate conjugates and complexes |
| 04/16/2009 | WO2005050170A3 Methods and compositions for inhibiting intracellular aggregate formation |
| 04/16/2009 | WO2005042727A3 Methods of organ regeneration |
| 04/16/2009 | WO2005040356A3 Mutant p53 protein and uses thereof |
| 04/16/2009 | WO2005035714A3 Vaccines for cancer, autoimmune disease and infections |
| 04/16/2009 | WO2005007806A3 Protein design for receptor-ligand recognition and binding |
| 04/16/2009 | WO2004074433A3 Rag polypeptides, nucleic acids, and their use |
| 04/16/2009 | WO2004039956A3 Compositions and methods for the treatment of immune related diseases |
| 04/16/2009 | US20090099826 Caspase-9:bir3 domain of xiap complexes and methods of use |
| 04/16/2009 | US20090099611 Biological pacemakers including mutated hyperpolarization-activated cyclic nucleotide-gated (hcn) channels |
| 04/16/2009 | US20090099533 Virus derived antimicrobial peptides |
| 04/16/2009 | US20090099434 Oxygen-effect free analyte sensor |
| 04/16/2009 | US20090099341 Heparanase specific molecular probes and their use in research and medical applications |
| 04/16/2009 | US20090099339 Antibody and antibody fragments for inhibiting the growth of tumors |
| 04/16/2009 | US20090099124 Short interfering rna as an antiviral agent for hepatitis c |
| 04/16/2009 | US20090099120 For modulating the expression of genes associated with respiratory and pulmonary disease, such as cholinergic muscarinic receptor genes; nucleic acids with a pyrimidine modification |
| 04/16/2009 | US20090099115 A chemically-modified nucleic acid molecule that comprises a sense strand with or without the 3' TT overhang, and a separate antisense strand with or without the 3' TT overhang; pyrimidine modification; cancer |
| 04/16/2009 | US20090099110 Antiviral oligonucleotides |
| 04/16/2009 | US20090099107 Methods and Compositions for Inhibition of Nuclear Factor kappaB |
| 04/16/2009 | US20090099098 peptide lysyl-glutamyl-asparagine acid capable of enhancing capillaries resistance; for treatment of purpura senilis; normalization of blood microcirculation |
| 04/16/2009 | US20090099097 Enzyme inhibition |
| 04/16/2009 | US20090099096 HIV proteases as therapeutic agents for inhibition and treatment of HIV infection in humans, administered in combination with other classes of HIV therapeutic agents, especially inhibitors of HIV reverse transcriptase |
| 04/16/2009 | US20090099095 Novel neuroprotective peptide |
| 04/16/2009 | US20090099094 Use of Somatostatin Agonists to Treat Medullary Thyroid Carcinoma |
| 04/16/2009 | US20090099093 Peptide Tyrosinase Inhibitors and Uses Thereof |
| 04/16/2009 | US20090099092 Methods for stimulating fibroblast proliferation using substance p analogs |
| 04/16/2009 | US20090099091 Oligopeptide Tyrosinase Inhibitors and Uses Thereof |
| 04/16/2009 | US20090099090 Of given sequence; human leukocyte antigen; induce cytotoxic T cells; use of them as cancer vaccines, and methods for treatment and prevention of cancers based on them |
| 04/16/2009 | US20090099089 administering to the site of the full thickness defect of articular cartilage, an osteochondral graft , an active growth factor e.g. purified bone morphogenetic protein (BMP) and a suitable carrier for the regeneration of the cartilage |
| 04/16/2009 | US20090099088 System for Inhibiting Pathogenicity in the Rice-Blast Fungus Magnaporthe Grisea |
| 04/16/2009 | US20090099087 Human kunitz-type inhibitor with enhanced antifibrinolytic activity |
| 04/16/2009 | US20090099086 Activin-ActRIIa antagonists and uses for promoting bone growth |
| 04/16/2009 | US20090099085 Amylin Derivatives |
| 04/16/2009 | US20090099084 Treatment |
| 04/16/2009 | US20090099083 Compositions for eliciting an immune response against mycobacterium avium subspecies paratuberculosis |
| 04/16/2009 | US20090099082 Production of polyurethane foams |
| 04/16/2009 | US20090099081 Synthetic axmi-004 delta-endotoxin genes and methods for their use |
| 04/16/2009 | US20090099080 Mitochondria-targeted anti-tumor agents |
| 04/16/2009 | US20090099079 Novel Fungal Enzymes |
| 04/16/2009 | US20090099078 Nogo Receptor Antagonists |
| 04/16/2009 | US20090099077 Treatment of rett syndrome and other disorders |
| 04/16/2009 | US20090099076 OBG3 Globular Head and Uses Thereof |
| 04/16/2009 | US20090099075 Chimeric Keratin-Binding Effector Proteins |
| 04/16/2009 | US20090099074 Modulating food intake |
| 04/16/2009 | US20090099073 Albumin Fusion Proteins |
| 04/16/2009 | US20090099072 Motif of the Beclin Protein Which Interacts with Anti-Apoptotic Members of the Bcl-2 Protein Family, and Uses |
| 04/16/2009 | US20090099071 Sugar chain-containing albumin, production method thereof and use thereof |
| 04/16/2009 | US20090099070 Methods and compositions for preventing and treating male erectile dysfunction and female sexual arousal disorder |
| 04/16/2009 | US20090099069 Modulators of alpha-synuclein toxicity |
| 04/16/2009 | US20090099067 Glycosylated with galactose-N-acetylgalactosamine; used for the introduction of exogenous nucleic acid sequences into the genome of avians in order to express the exogenous sequences to alter the phenotype of the avians or to produce desired proteins |
| 04/16/2009 | US20090099066 Tissue specific peptide conjugates and methods |
| 04/16/2009 | US20090099065 Acylated Single Chain Insulin |
| 04/16/2009 | US20090099064 Derivatized insulin oligomers |
| 04/16/2009 | US20090099063 Ssx-2 peptides presented by hla class ii molecules |
| 04/16/2009 | US20090099062 Pyrvinium For The Treatment of Cancer |
| 04/16/2009 | US20090099061 Synthesis of carotenoid analogs or derivatives with improved antioxidant characteristics |
| 04/16/2009 | US20090099060 Modulation of line-1 reverse transcriptase |
| 04/16/2009 | US20090099037 Genomic Screen for Epigenetically Silenced Genes Associated With Cancer |
| 04/16/2009 | US20090099028 Protein binding miniature proteins and uses thereof |
| 04/16/2009 | US20090098636 Fungal cell wall synthesis gene |
| 04/16/2009 | US20090098631 Novel glutamic acid decarboxylase (GAD) proteins and methods of use |
| 04/16/2009 | US20090098609 Il-2 fusion proteins with modulated selectivity |
| 04/16/2009 | US20090098569 Novel PGC-1 Isoforms and Uses Therefor |
| 04/16/2009 | US20090098565 MeCP2E1 gene |